1. Home
  2. KN vs MESO Comparison

KN vs MESO Comparison

Compare KN & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KN
  • MESO
  • Stock Information
  • Founded
  • KN 1946
  • MESO 2004
  • Country
  • KN United States
  • MESO Australia
  • Employees
  • KN N/A
  • MESO N/A
  • Industry
  • KN Consumer Electronics/Appliances
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KN Consumer Staples
  • MESO Health Care
  • Exchange
  • KN Nasdaq
  • MESO Nasdaq
  • Market Cap
  • KN 1.8B
  • MESO 1.7B
  • IPO Year
  • KN N/A
  • MESO N/A
  • Fundamental
  • Price
  • KN $15.20
  • MESO $12.48
  • Analyst Decision
  • KN Hold
  • MESO Buy
  • Analyst Count
  • KN 1
  • MESO 4
  • Target Price
  • KN $19.00
  • MESO $18.00
  • AVG Volume (30 Days)
  • KN 871.0K
  • MESO 305.9K
  • Earning Date
  • KN 04-30-2025
  • MESO 02-26-2025
  • Dividend Yield
  • KN N/A
  • MESO N/A
  • EPS Growth
  • KN N/A
  • MESO N/A
  • EPS
  • KN N/A
  • MESO N/A
  • Revenue
  • KN $553,500,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • KN $6.21
  • MESO $228.57
  • Revenue Next Year
  • KN $8.13
  • MESO $356.77
  • P/E Ratio
  • KN N/A
  • MESO N/A
  • Revenue Growth
  • KN 21.17
  • MESO N/A
  • 52 Week Low
  • KN $14.95
  • MESO $4.60
  • 52 Week High
  • KN $20.86
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • KN 27.90
  • MESO 34.58
  • Support Level
  • KN $15.73
  • MESO $13.60
  • Resistance Level
  • KN $16.45
  • MESO $14.45
  • Average True Range (ATR)
  • KN 0.38
  • MESO 0.49
  • MACD
  • KN 0.01
  • MESO 0.02
  • Stochastic Oscillator
  • KN 15.72
  • MESO 23.50

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: